280 related articles for article (PubMed ID: 23828139)
1. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
Wang L; Zhu R; Huang Z; Li H; Zhu H
Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
[TBL] [Abstract][Full Text] [Related]
2. CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway.
Wang Y; Tu Q; Yan W; Xiao D; Zeng Z; Ouyang Y; Huang L; Cai J; Zeng X; Chen YJ; Liu A
Biochem Biophys Res Commun; 2015 Jan; 456(1):373-9. PubMed ID: 25475726
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide-induced toll-like receptor 4 signaling in esophageal squamous cell carcinoma promotes tumor proliferation and regulates inflammatory cytokines expression.
Zu Y; Ping W; Deng T; Zhang N; Fu X; Sun W
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27061118
[TBL] [Abstract][Full Text] [Related]
4. A896G and C1196T Polymorphisms Within the TLR4 Gene Abate Toll-Like Receptor 4-Mediated Signaling in HepG2 Cells.
Huang C; Zhang H; Bai R; Wang L; Lv J
DNA Cell Biol; 2017 Nov; 36(11):1029-1038. PubMed ID: 28945461
[TBL] [Abstract][Full Text] [Related]
5. Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.
Xu D; Wang X; Yan S; Yin Y; Hou J; Wang X; Sun B
Tumour Biol; 2014 Oct; 35(10):10267-73. PubMed ID: 25034527
[TBL] [Abstract][Full Text] [Related]
6. Cynatratoside-C from Cynanchum atratum displays anti-inflammatory effect via suppressing TLR4 mediated NF-κB and MAPK signaling pathways in LPS-induced mastitis in mice.
Hu G; Hong D; Zhang T; Duan H; Wei P; Guo X; Mu X
Chem Biol Interact; 2018 Jan; 279():187-195. PubMed ID: 29113806
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway.
Dong YQ; Lu CW; Zhang L; Yang J; Hameed W; Chen W
Mol Immunol; 2015 Dec; 68(2 Pt C):671-83. PubMed ID: 26589455
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells.
Wang Y; Zhang MX; Meng X; Liu FQ; Yu GS; Zhang C; Sun T; Wang XP; Li L; Wang YY; Ding SF; Yang JM; Zhang Y
Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1743-52. PubMed ID: 21317307
[TBL] [Abstract][Full Text] [Related]
9. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1.
Yang H; Young DW; Gusovsky F; Chow JC
J Biol Chem; 2000 Jul; 275(27):20861-6. PubMed ID: 10877845
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide.
Jing YY; Han ZP; Sun K; Zhang SS; Hou J; Liu Y; Li R; Gao L; Zhao X; Zhao QD; Wu MC; Wei LX
BMC Med; 2012 Aug; 10():98. PubMed ID: 22938142
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells.
Hsiao CC; Chen PH; Cheng CI; Tsai MS; Chang CY; Lu SC; Hsieh MC; Lin YC; Lee PH; Kao YH
Cancer Lett; 2015 Nov; 368(1):144-152. PubMed ID: 26276725
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4.
Wei X; Liu H; Li X; Liu X
Ann Hepatol; 2019; 18(6):869-878. PubMed ID: 31477445
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
[TBL] [Abstract][Full Text] [Related]
14. Total flavonoids of Radix Tetrastigma suppress inflammation-related hepatocellular carcinoma cell metastasis.
Liu Z; Ding F; Shen X
Mol Genet Genomics; 2021 May; 296(3):571-579. PubMed ID: 33576897
[TBL] [Abstract][Full Text] [Related]
15. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
[TBL] [Abstract][Full Text] [Related]
16. Persistent TLR4 Activation Promotes Hepatocellular Carcinoma Growth through Positive Feedback Regulation by LIN28A/Let-7g miRNA.
Chen IT; Cheng AC; Liu YT; Yan C; Cheng YC; Chang CF; Tseng PH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955552
[TBL] [Abstract][Full Text] [Related]
17. LPS promotes epithelial-mesenchymal transition and activation of TLR4/JNK signaling.
Li H; Li Y; Liu D; Liu J
Tumour Biol; 2014 Oct; 35(10):10429-35. PubMed ID: 25053598
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
[TBL] [Abstract][Full Text] [Related]
19. TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma.
Zhou S; Du R; Wang Z; Shen W; Gao R; Jiang S; Fang Y; Shi Y; Chang A; Liu L; Liu C; Li N; Xiang R
Cancer Med; 2019 May; 8(5):2325-2337. PubMed ID: 30957973
[TBL] [Abstract][Full Text] [Related]
20. TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.
Szajnik M; Szczepanski MJ; Czystowska M; Elishaev E; Mandapathil M; Nowak-Markwitz E; Spaczynski M; Whiteside TL
Oncogene; 2009 Dec; 28(49):4353-63. PubMed ID: 19826413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
